关键词：治疗性疫苗；机体免疫力；患病细胞；组织
摘 要：A therapeutic vaccine is a biological combination developed to improve immunity by inducing an attack against a diseased cell or tissue. This kind of vaccine differs from the prophylactic vaccine, which is administered to a diseased individual to induce a defense mechanism. There are two approved therapeutic vaccines namely Provenge and Oncophage. A large number of therapeutic vaccines are under clinical development and are expected to be approved for use during the forecast period. In 2013, a large fraction of the growth of the Global Therapeutic Vaccines market stemmed from the Americas, which accounted for 90 percent of the market. The EMEA region accounted for less than 10 percent of the market. While it is expected that the revenue from the APAC region will grow exponentially during the forecast period, owing to increased acceptance of therapeutic vaccines; there are no such approved products in this region currently. The market is expected to grow at a CAGR of 62.81 percent during the forecast period.
目 录：

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

03.1 Market Overview

03.2 Product Offerings

04. Market Research Methodology

04.1 Market Research Process

04.2 Research Methodology

05. Introduction

06. Market Landscape

06.1 Market Overview

06.2 Market Size and Forecast

06.3 Five Forces Analysis

07. Geographical Segmentation

08. Key Leading Countries

08.1 USA

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Pipeline Analysis

17. Vendor Landscape

17.1 Competitive Scenario

17.1.1 Key News

17.1.2 Mergers and Acquisitions

17.2 Other Prominent Vendors

18. Key Vendor Analysis

18.1 Agenus Inc.

18.1.1 Business Overview

18.1.2 Key Information

18.1.3 SWOT Analysis

18.2 Bavarian Nordic A/S

18.2.1 Business Overview

18.2.2 Business Segmentation

18.2.3 Key Information

18.2.4 SWOT Analysis

18.3 Dendreon Corp

18.3.1 Business Overview

18.3.2 Key Information

18.3.3 SWOT Analysis

18.4 GlaxoSmithKline plc

18.4.1 Business Overview

18.4.2 Business Segmentation

18.4.3 Key Information

18.4.4 SWOT Analysis

18.5 Novartis International AG

18.5.1 Business Overview

18.5.2 Business Segmentation

18.5.3 Key Information

18.5.4 SWOT Analysis

19. Other Reports in this Series